CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 253 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $4,897,000 | -95.4% | 48,651 | -96.9% | 0.00% | -95.5% |
Q3 2014 | $105,670,000 | -6.9% | 1,592,859 | -2.0% | 0.09% | -7.3% |
Q2 2014 | $113,458,000 | -3.6% | 1,625,006 | +1.0% | 0.10% | -5.9% |
Q1 2014 | $117,684,000 | +38.4% | 1,608,810 | +30.3% | 0.10% | +34.2% |
Q4 2013 | $85,045,000 | -22.8% | 1,234,860 | -28.8% | 0.08% | -30.3% |
Q3 2013 | $110,154,000 | +54.6% | 1,733,348 | +17.5% | 0.11% | +43.4% |
Q2 2013 | $71,262,000 | – | 1,475,397 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |